TY - JOUR
T1 - Long-term outcomes after liver transplantation in the Hispanic population
AU - Ochoa-Allemant, Pedro
AU - Ezaz, Ghideon
AU - Trivedi, Hirsh D.
AU - Sanchez-Fernandez, Lady
AU - Bonder, Alan
N1 - Publisher Copyright:
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
PY - 2020/2/1
Y1 - 2020/2/1
N2 - Background & Aims: Racial/ethnic disparities in liver transplantation (LT) are well-recognized. Although Hispanics represent the largest and youngest minority group in the United States, limited data exist on long-term outcomes. We aimed to investigate long-term post-liver transplant outcomes in Hispanic patients and identify potential disparities compared to a baseline demographic of non-Hispanic white patients. Methods: We performed a retrospective cohort study of first-time liver transplant recipients using the United Network for Organ Sharing database from 2002 to 2013, with follow-up through 2018. The primary outcomes of interest were overall patient and graft survival after LT. Results: 45 767 patients underwent LT (85.0% non-Hispanic white, 15.0% Hispanic). Hispanics had lower socioeconomic status, higher prevalence of pretransplant comorbidities and more severe liver disease compared to non-Hispanic whites. Hispanics had similar patient (76.6% vs 75.6%; P =.12) and graft (71.7% vs 70.8%; P =.28) survival at 5 years and significantly better patient (62.9% vs 59.7%; P <.001) and graft (58.6% vs 55.6%; P =.002) survival at 10 years. In multivariable analysis, Hispanics had lower associated all-cause mortality (HR 0.86, 95% CI, 0.82-0.91; P <.001) and graft failure (HR 0.89, 95% CI, 0.85-0.93; P <.001) compared to non-Hispanic whites. In etiology-specific subanalysis, Hispanics transplanted for ALD, NASH and HCV had lower all-cause mortality compared to non-Hispanic whites. Conclusions: Hispanics have similar or better long-term post-LT outcomes compared to non-Hispanic whites despite a worse pretransplant risk factor profile. Further research is needed to clarify if this survival advantage reflects uncaptured protective factors or more stringent transplant selection in the Hispanic population.
AB - Background & Aims: Racial/ethnic disparities in liver transplantation (LT) are well-recognized. Although Hispanics represent the largest and youngest minority group in the United States, limited data exist on long-term outcomes. We aimed to investigate long-term post-liver transplant outcomes in Hispanic patients and identify potential disparities compared to a baseline demographic of non-Hispanic white patients. Methods: We performed a retrospective cohort study of first-time liver transplant recipients using the United Network for Organ Sharing database from 2002 to 2013, with follow-up through 2018. The primary outcomes of interest were overall patient and graft survival after LT. Results: 45 767 patients underwent LT (85.0% non-Hispanic white, 15.0% Hispanic). Hispanics had lower socioeconomic status, higher prevalence of pretransplant comorbidities and more severe liver disease compared to non-Hispanic whites. Hispanics had similar patient (76.6% vs 75.6%; P =.12) and graft (71.7% vs 70.8%; P =.28) survival at 5 years and significantly better patient (62.9% vs 59.7%; P <.001) and graft (58.6% vs 55.6%; P =.002) survival at 10 years. In multivariable analysis, Hispanics had lower associated all-cause mortality (HR 0.86, 95% CI, 0.82-0.91; P <.001) and graft failure (HR 0.89, 95% CI, 0.85-0.93; P <.001) compared to non-Hispanic whites. In etiology-specific subanalysis, Hispanics transplanted for ALD, NASH and HCV had lower all-cause mortality compared to non-Hispanic whites. Conclusions: Hispanics have similar or better long-term post-LT outcomes compared to non-Hispanic whites despite a worse pretransplant risk factor profile. Further research is needed to clarify if this survival advantage reflects uncaptured protective factors or more stringent transplant selection in the Hispanic population.
KW - Hispanic
KW - end–stage liver disease
KW - healthcare disparities
KW - liver transplantation
KW - survival analysis
UR - http://www.scopus.com/inward/record.url?scp=85073980966&partnerID=8YFLogxK
U2 - 10.1111/liv.14248
DO - 10.1111/liv.14248
M3 - Article
C2 - 31505081
AN - SCOPUS:85073980966
SN - 1478-3223
VL - 40
SP - 437
EP - 446
JO - Liver International
JF - Liver International
IS - 2
ER -